Article Details

Eiger Biopharmaceuticals (EIGR) Stock is Higher After Inclusion in COVID-19 Study

Retrieved on: 2021-05-03 18:11:15

Tags for this article:

Click the tags to see associated articles and topics

Eiger Biopharmaceuticals (EIGR) Stock is Higher After Inclusion in COVID-19 Study. View article details on hiswai:

Excerpt

Eiger Biopharmaceuticals (EIGR) stock is higher today after the company announced that its lead clinical drug, Peginterferon Lambda (Lambda), will ...

Article found on: www.investorsobserver.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up